期刊文献+

白藜芦醇联合顺铂对FRH-0201细胞的影响 被引量:2

Effect of resveratrol combined with DDP on FRH-0201 cholangiocarcinoma cell line
下载PDF
导出
摘要 目的:探讨白藜芦醇(RES)与顺铂(DDP)联合应用对肝门部胆管癌细胞系FRH-0201的影响。方法:不同浓度的RES、DDP单独及联合作用FRH-0201细胞不同的时间,光学显微镜观察细胞形态学变化;MTT比色法和集落形成实验检测细胞增殖抑制作用;流式细胞术检测细胞周期改变及细胞凋亡率。结果:RES在5~320μmo/lL浓度范围内能够抑制FRH-0201细胞的增殖,并呈剂量-时间依赖关系,其作用24、48和72h的IC50分别为55.35、32.84和28.01μmol/L。RES+DDP联合应用的细胞抑制率和诱导凋亡率较二者单独作用显著升高(P<0.05)。结论:RES对FRH-0201细胞具有抑制作用,RES+DDP联合应用具有协同作用。 Objcetive: To investigate the effect of resveratrol (RES)combined with cisplatin (DDP)on the cholangiocarcinoma cell line FRH-0201 in vitro. Methods: FRH-0201 cells were exposed to different concentrations of RES or (and)DDP. Cell morphological changes were observed by light and fluorescence microscopy. Inhibition of cell proliferation was measured by MTT and colony-forming assay. And the flow cytometry were performed to detect the cell apoptosis rate and cell cycle. Results: Resveratrol inhibited the proliferation of FRH-0201 cells in a time-and dose-dependent manner in the concentration of 5~320 μmol/L and the IC50 values after the exposure of 24, 48, and 72 h were 55.35, 32.84, and 28.01 μmol/L respectively. RES and DDP had synergetic effect in the inhibition of FRH-0201 cells. Conclusion: RES can inhibit the growth of FRH-0201 cells and has the synergetic effect with DDP.
出处 《中国现代普通外科进展》 CAS 2009年第12期1033-1035,共3页 Chinese Journal of Current Advances in General Surgery
关键词 胆管肿瘤·白藜芦醇·顺铂 Bile duct neoplasms·Resveratrol·Cisplatin
  • 相关文献

参考文献6

  • 1Bhat KP, Pezzuto JM. Cancer chemopreventive activity of resveratrol [d]. Ann N Y Acad Sci, 2002,957:210-229.
  • 2李胜昔,曾斌.白藜芦醇致肿瘤细胞凋亡作用的研究进展[J].肿瘤基础与临床,2007,20(6):547-549. 被引量:3
  • 3李志伟,王占民,吴小鹏,常新忠,马道新,丛超.利用裸鼠建立人肝门部胆管癌肝门移植模型[J].中国现代普通外科进展,2004,7(4):209-211. 被引量:4
  • 4Hayashihara T, Yamada Y, Nakayama S, et al. Resveratrol induces downregulation in survivin expressiun and apoptosis in HTLV-I-infected cell lines: a prospective agent for adult T cell leukemia chemotherapy[J]. Nutr Cancer, 2002,44 (2): 193-201.
  • 5Pozo-Guisado E, Merino JM, Mulero-Navarro S, et al. Resveratrol induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl-2 and NF-kappaB[J]. Int J Cancer, 2005,115 ( 1 ):74-84.
  • 6She QB, Bode AM, Ma WY, et al. Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase[J]. Cancer Res, 2001,61(4):1604-1610.

二级参考文献10

共引文献5

同被引文献22

  • 1焦慧琴,王蕤,孙海梅,刘永,郭敏,苏红星,周德山.白藜芦醇对人皮肤癌细胞株A431生长抑制机制实验研究[J].首都医科大学学报,2009,30(2):212-217. 被引量:10
  • 2Fulda S,Debatin KM.Sensitization for tumor necrosis factor-re-lated apoptosis-inducing ligand-induced apoptosis by the chemo-preventive agent resveratrol[J].Cancer Res,2004,64(1):337-346.
  • 3Bhardwaj A,Sethi G,Vadhan-Raj S,et al.Resveratrol inhibitsproliferation,induces apoptosis,and overcomes chemoresistancethrough down-regulation of STAT3and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in humanmultiple myeloma cells[J].Blood,2007,109(6):2293-2302.
  • 4Deleu S,Lemaire M,Arts J,et al.Bortezomib alone or in com-bination with the histone deacetylase inhibitor JNJ-26481585:effect on myeloma bone disease in the 5T2MM murine model ofmyeloma[J].Cancer Res,2009,69(13):5307-5311.
  • 5Zhang W,Wang X,Chen T.Resveratrol induces mitochondria-mediated AIF and to a lesser extent caspase-9-dependent apopto-sis in human lung adenocarcinoma ASTC-a-1cells[J].Mol CellBiochem,2011,354(1-2):29-37.
  • 6Touzet O,Philips A.Resveratrol protects against protease inhib-itor-induced reactive oxygen species production,reticulum stressand lipid raft perturbation[J].AIDS,2010,24(10):1437-1447.
  • 7ANKIT J,KANIKA T,PREETI K,et al.Docetaxel loaded chitosan nanoparticles:Formulation,characterization and cytotoxicity studies[J].International Journal of Biological Macromolecules,2014,69:546-553.
  • 8SIMONE F.Resveratrol and derivatives for the prevention and treatment of cancer[J].Drug Discovery Today,2010,15(17-18):757-765.
  • 9GURINDER S,PAI S R.Recent advances of resveratrol in nanostructured based delivery systems and in the management of HIV/AIDS[J].Journal of Controlled Release,2014,194:178-188.
  • 10DAS M,DAS D K.Resveratrol and cardiovascular health[J].Molecular Aspects of Medicine,2010,31(6):503-512.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部